Erythropoietin doubles the incidence of microvascular obstruction in primary PCI - a randomized controlled trial in acute MI using CMR primary endpoints

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1532-429X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Erythropoietin doubles the incidence of microvascular obstruction in primary PCI - a randomized controlled trial in acute MI using CMR primary endpoints ; volume:12 ; number:1 ; day:21 ; month:1 ; year:2010 ; pages:1-2 ; date:1.2010
Journal of cardiovascular magnetic resonance ; 12, Heft 1 (21.1.2010), 1-2, 1.2010

Creator: Ludman, Andrew J.

Contributor: Hasleton, Jonathan M.
Babu, Girish
Boston-Griffiths, Edney
Moon, James C.
Muthurangu, Vivek
Taylor, Andrew M.
Puranik, Raj
Yellon, Derek
Hausenloy, Derek J.
SpringerLink (Online service)

DOI: 10.1186/1532-429X-12-S1-O78

URN: urn:nbn:de:1111-201603229377

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:54 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show object at data provider

Associated

Ludman, Andrew J.
Hasleton, Jonathan M.
Babu, Girish
Boston-Griffiths, Edney
Moon, James C.
Muthurangu, Vivek
Taylor, Andrew M.
Puranik, Raj
Yellon, Derek
Hausenloy, Derek J.
SpringerLink (Online service)

Other Objects (12)

Impaired myocardial perfusion on CMR is associated with increased numbers of classical monocytes in STEMI patients treated by primary PCI

Impaired myocardial perfusion on CMR is associated with increased numbers of classical monocytes in STEMI patients treated by primary PCI

CMR detects a reduction in infarct size and myocardial edema when primary PCI is augmented by Remote Ischemic Conditioning. A randomized trial

CMR detects a reduction in infarct size and myocardial edema when primary PCI is augmented by Remote Ischemic Conditioning. A randomized trial

Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach

Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach

Infarct burden following multivessel PCI vs. infarct-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study

Infarct burden following multivessel PCI vs. infarct-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study

Point of care platelet activity measurement in primary PCI [PINPOINT-PPCI]: a protocol paper

Point of care platelet activity measurement in primary PCI [PINPOINT-PPCI]: a protocol paper

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro

Left ventricular outcomes following multivessel PCI vs. infarct artery-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study

Left ventricular outcomes following multivessel PCI vs. infarct artery-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study

NT-proBNP during and after primary PCI for improved scheduling of early hospital discharge

NT-proBNP during and after primary PCI for improved scheduling of early hospital discharge

CMR endpoints for clinical trials: impact of operator experience on the accuracy of image analysis

CMR endpoints for clinical trials: impact of operator experience on the accuracy of image analysis

Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons

Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons

Physicians’ Perception of the Evidence in Relation to Primary Endpoints of Clinical Trials on Breast Cancer

Physicians’ Perception of the Evidence in Relation to Primary Endpoints of Clinical Trials on Breast Cancer

Seamless phase 2/3 design for trials with multiple co-primary endpoints using Bayesian predictive power

Seamless phase 2/3 design for trials with multiple co-primary endpoints using Bayesian predictive power

Impaired myocardial perfusion on CMR is associated with increased numbers of classical monocytes in STEMI patients treated by primary PCI

Impaired myocardial perfusion on CMR is associated with increased numbers of classical monocytes in STEMI patients treated by primary PCI

CMR detects a reduction in infarct size and myocardial edema when primary PCI is augmented by Remote Ischemic Conditioning. A randomized trial

CMR detects a reduction in infarct size and myocardial edema when primary PCI is augmented by Remote Ischemic Conditioning. A randomized trial

Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach

Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach

Infarct burden following multivessel PCI vs. infarct-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study

Infarct burden following multivessel PCI vs. infarct-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study

Point of care platelet activity measurement in primary PCI [PINPOINT-PPCI]: a protocol paper

Point of care platelet activity measurement in primary PCI [PINPOINT-PPCI]: a protocol paper

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro

Left ventricular outcomes following multivessel PCI vs. infarct artery-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study

Left ventricular outcomes following multivessel PCI vs. infarct artery-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study

NT-proBNP during and after primary PCI for improved scheduling of early hospital discharge

NT-proBNP during and after primary PCI for improved scheduling of early hospital discharge

CMR endpoints for clinical trials: impact of operator experience on the accuracy of image analysis

CMR endpoints for clinical trials: impact of operator experience on the accuracy of image analysis

Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons

Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons

Physicians’ Perception of the Evidence in Relation to Primary Endpoints of Clinical Trials on Breast Cancer

Physicians’ Perception of the Evidence in Relation to Primary Endpoints of Clinical Trials on Breast Cancer

Seamless phase 2/3 design for trials with multiple co-primary endpoints using Bayesian predictive power

Seamless phase 2/3 design for trials with multiple co-primary endpoints using Bayesian predictive power

Impaired myocardial perfusion on CMR is associated with increased numbers of classical monocytes in STEMI patients treated by primary PCI

Impaired myocardial perfusion on CMR is associated with increased numbers of classical monocytes in STEMI patients treated by primary PCI

CMR detects a reduction in infarct size and myocardial edema when primary PCI is augmented by Remote Ischemic Conditioning. A randomized trial

CMR detects a reduction in infarct size and myocardial edema when primary PCI is augmented by Remote Ischemic Conditioning. A randomized trial

Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach

Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach

Infarct burden following multivessel PCI vs. infarct-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study

Infarct burden following multivessel PCI vs. infarct-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study

Point of care platelet activity measurement in primary PCI [PINPOINT-PPCI]: a protocol paper

Point of care platelet activity measurement in primary PCI [PINPOINT-PPCI]: a protocol paper

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro

Left ventricular outcomes following multivessel PCI vs. infarct artery-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study

Left ventricular outcomes following multivessel PCI vs. infarct artery-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study

NT-proBNP during and after primary PCI for improved scheduling of early hospital discharge

NT-proBNP during and after primary PCI for improved scheduling of early hospital discharge

CMR endpoints for clinical trials: impact of operator experience on the accuracy of image analysis

CMR endpoints for clinical trials: impact of operator experience on the accuracy of image analysis

Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons

Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons

Physicians’ Perception of the Evidence in Relation to Primary Endpoints of Clinical Trials on Breast Cancer

Physicians’ Perception of the Evidence in Relation to Primary Endpoints of Clinical Trials on Breast Cancer

Seamless phase 2/3 design for trials with multiple co-primary endpoints using Bayesian predictive power

Seamless phase 2/3 design for trials with multiple co-primary endpoints using Bayesian predictive power

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read and agree to the privacy policy for the collection of personal data.*

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.